Sernova Corp. is a clinical stage regenerative medicine company, which engages in the development and commercialization of proprietary technologies, including Cell Pouch implantable device technologies and immune-protected therapeutic cells. The company was founded on August 19, 1998 and is headquartered in London, Canada.